DOCSLIB.ORG

Portfolio Leading Research and Reviews Across the Life Sciences

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Portfolio Leading Research and Reviews Across the Life Sciences life portfolio leading research and reviews across the life sciences Nature, the #1 journal in Multidisciplinary Sciences All the life sciences Nature research 5 of the Nature Reviews journals are the top journals are in the top 10 in their category* monthly review journal in their category* Nature Biotechnology* Nature Reviews Drug Discovery* Nature Cell Biology Nature Reviews Genetics* Nature Chemical Biology Nature Reviews Microbiology* Nature Genetics* Nature Reviews Neuroscience* Nature Immunology* Nature Reviews Molecular Cell Biology* Nature Medicine (#1 in Medicine, Research & Experimental)* Nature Neuroscience Nature Structural & Molecular Biology* For a free trial for your institution, contact [email protected] *2014 Journal Citation Reports®, Science Edition (Thomson Reuters, 2015) Request a free trial or site license quote today We are happy to offer you and your users a free trial to any of the journals. To arrange this, request a quote, or to ask any questions, please contact your sales representative or your local office via the email address below. Contact North America: [email protected] Latin America (excluding Brazil): [email protected] Brazil: [email protected] Asia Pacific: [email protected] Australia and New Zealand: [email protected] India: [email protected] UK/Europe/ROW: [email protected] www.nature.com new Nature Medicine Nature Microbiology #1 for Nature Research has a strong tradition in the life sciences, beginning with its flagship journal Nature, which has been ISSN: 1078-8956 in Medicine, ISSN: 2058-5276 (online) Research & publishing the most important scholarly research in science and technology since 1869. The life sciences portfolio also Impact Factor: 27.363* Experimental Impact Factor: Due in 2019 2016 includes the authoritative Nature research journals and the acclaimed Nature Reviews series. The publications in the life Nature Medicine covers the latest and most exciting Launching in January 2016, Nature Microbiology will be sciences portfolio are all leading titles in their fields, meaning you can select them with confidence. advances in biomedical research for scientists a monthly, online-only journal dedicated to publishing and physicians, with an emphasis on clarity of primary research papers in microbiology. The cutting- presentation. The journal publishes cutting-edge edge research will be complemented by expert News articles, ensuring readers stay current on the and Views, Reviews and Commentaries that help place latest advances in biomedical research. Articles the research in context, providing readers with a broad cover fields such as cancer biology, cardiovascular perspective on the entire field. #2 Nature Nature Biotechnology primary research research, gene therapy, immunology, vaccine #1 journal in development, and neuroscience, and put in Multidisciplinary Biotechnology www.nature.com/nmicrobiol ISSN: 0028-0836 ISSN: 0028-0836 & Applied Sciences developments in science into a medical context. Impact Factor: 41.456* Impact Factor: 41.514* Microbiology Nature is the leading weekly international journal, Nature Biotechnology covers the science and www.nature.com/nm publishing the finest peer-reviewed research in all business of biotechnology. The journal publishes fields of science and technology – a tradition that we applied research of relevance to the biological, have maintained for over a century. The journal also biomedical, agricultural and environmental provides rapid, authoritative and insightful news and sciences as well as the commercial, political, interpretation of topical and emerging trends affecting ethical, legal and societal aspects of this research. science, scientists and the wider public. Some issues Nature Neuroscience demand more in-depth coverage and so, on top of the www.nature.com/nbt Nature Structural & regular weekly content, Nature also publishes a series ISSN: 1097-6256 Molecular Biology #2 of topical Insights, Supplements and Online Specials. Impact Factor: 16.095* primary research ISSN: 1545-9993 journal in Impact Factor: 13.309* Biophysics www.nature.com/nature Nature Neuroscience publishes the most exciting and influential developments in all areas of neuroscience. Nature Structural & Molecular Biology places a The journal covers advances related to molecular, strong emphasis on the molecular mechanisms cellular, systems, behavioral, cognitive and underlying biological processes. The journal computational studies. A lively front half, which includes covers topics including: DNA replication; repair News & Views, Reviews, Book Reviews and editorials, and recombination; transcription; the folding, helps place the primary research in context, providing Nature Cell Biology Nature Chemical Biology processing, transport and degradation of proteins readers with a broad perspective on the entire field. and RNA; and signal transduction. ISSN: 1465-7392 ISSN: 1552-4450 Impact Factor: 19.679* Impact Factor: 12.996* www.nature.com/neuro www.nature.com/nsmb Nature Cell Biology publishes papers in all areas of Nature Chemical Biology is committed to the publication cell biology, with a particular emphasis on studies of top tier original research and commentary at the shedding light on molecular mechanism. Every interface of chemistry, biology and allied disciplines. issue includes the latest peer-reviewed original The journal publishes original research in two formats, research as well as a timely and informative Brief Communications and Articles. Each issue also The Nature Reviews journals provide close examination and analysis of current research in each of the major disciplines. Alongside features a diverse selection of other articles including collection of News & Views articles, book reviews review articles and research highlights, issues typically contain: and editorials. Editorials, Commentaries, Reviews, Perspectives, Interviews, Research Highlights and Meeting Reports • Perspectives – articles that cover issues from historical foundations and influences, opinion and innovation to the implications and www.nature.com/ncb designed to keep readers aware of frontier areas in this rapidly moving field. applications of science in society, enabling readers to put research into context. www.nature.com/nchembio • Progress Articles and News & Views – short, timely articles that focus on current papers of outstanding interest that are setting new standards and expanding knowledge in the field. Nature Genetics #2 Nature Immunology primary research #2 #1 #1 #2 journal in Genetics monthly review monthly review monthly review monthly review ISSN: 1061-4036 ISSN: 1529-2908 journal in Oncology journal in journal in Genetics journal in & Heredity Pharmacology & & Heredity Immunology Impact Factor: 29.352* Impact Factor: 20.004* Pharmacy Nature Genetics is the primary research journal Nature Immunology brings together the most significant ISSN: 1474-175X ISSN: 1474-1776 ISSN: 1471-0056 ISSN: 1474-1733 for the genetics community. The journal delivers immunology research from across the field. The journal’s Impact Factor: 37.400* Impact Factor: 41.908* Impact Factor: 36.978* Impact Factor: 34.985* the latest research across the field, including scope is broad, covering all areas of immunology human genetics and genomics, epigenetics, cancer, including: innate immunity and inflammation, chromosome biology and genetic technology. Current immune receptors, signaling and apoptosis, gene emphasis is on the genetic basis for common and regulation and recombination, cellular and systemic #1 #1 #1 monthly review monthly review monthly review journal in journal in journal in complex diseases and on the functional mechanism, immunity, vaccines, tumor immunology, microbial Microbiology Cell Biology Neurosciences architecture and evolution of gene networks. immunopathology and transplantation. ISSN: 1740-1526 ISSN: 1471-0072 ISSN: 1471-003X www.nature.com/ng www.nature.com/ni Impact Factor: 23.574* Impact Factor: 37.806* Impact Factor: 31.427* *2014 Journal Citation Reports®, Science Edition (Thomson Reuters, 2015).
Load more

Recommended publications
  • Guide to Publication Policies of the Nature Journals
    GUIDE TO PUBLICATION POLICIES OF THE NATURE JOURNALS Last updated on 30 April 2009. Editorial Policies NATURE JOURNALS' POLICIES ON PUBLICATION ETHICS Nature journals' authorship policy Being an author The Nature journals do not require all authors of a research paper to sign the letter of submission, nor do they impose an order on the list of authors. Submission to a Nature journal is taken by the journal to mean that all the listed authors have agreed all of the contents. The corresponding (submitting) author is responsible for having ensured that this agreement has been reached, and for managing all communication between the journal and all co-authors, before and after publication. Any changes to the author list after submission, such as a change in the order of the authors, or the deletion or addition of authors, needs to be approved by a signed letter from every author. Responsibilities of senior team members on multi-group collaborations The editors at the Nature journals assume that at least one member of each collaboration, usually the most senior member of each submitting group or team, has accepted responsibility for the contributions to the manuscript from that team. This responsibility includes, but is not limited to: (1) ensuring that original data upon which the submission is based is preserved and retrievable for reanalysis; (2) approving data presentation as representative of the original data; and (3) foreseeing and minimizing obstacles to the sharing of data, materials, algorithms or reagents described in the work. Author contributions statementsAuthors are required to include a statement of responsibility in the manuscript that specifies the contribution of every author.
    [Show full text]
  • Tissue and Cell
    TISSUE AND CELL AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 0040-8166 DESCRIPTION . Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed. Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature. IMPACT FACTOR . 2020: 2.466 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus PubMed/Medline Cambridge Scientific Abstracts Current Awareness in Biological Sciences Current Contents - Life Sciences Embase Embase Science Citation Index Web of Science EDITORIAL BOARD . Editor Pietro Lupetti, University of Siena, Siena, Italy AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/tice 1 Managing Editor Giacomo Spinsanti, University of Siena,
    [Show full text]
  • The Nature Index Journals
    The Nature Index journals The current 12-month window on natureindex.com includes data from 57,681 primary research articles from the following science journals: Advanced Materials (1028 articles) American Journal of Human Genetics (173 articles) Analytical Chemistry (1633 articles) Angewandte Chemie International Edition (2709 articles) Applied Physics Letters (3609 articles) Astronomy & Astrophysics (1780 articles) Cancer Cell (109 articles) Cell (380 articles) Cell Host & Microbe (95 articles) Cell Metabolism (137 articles) Cell Stem Cell (100 articles) Chemical Communications (4389 articles) Chemical Science (995 articles) Current Biology (440 articles) Developmental Cell (204 articles) Earth and Planetary Science Letters (608 articles) Ecology (259 articles) Ecology Letters (120 articles) European Physical Journal C (588 articles) Genes & Development (193 articles) Genome Research (184 articles) Geology (270 articles) Immunity (159 articles) Inorganic Chemistry (1345 articles) Journal of Biological Chemistry (2639 articles) Journal of Cell Biology (229 articles) Journal of Clinical Investigation (298 articles) Journal of Geophysical Research: Atmospheres (829 articles) Journal of Geophysical Research: Oceans (493 articles) Journal of Geophysical Research: Solid Earth (520 articles) Journal of High Energy Physics (2142 articles) Journal of Neuroscience (1337 articles) Journal of the American Chemical Society (2384 articles) Molecular Cell (302 articles) Monthly Notices of the Royal Astronomical Society (2946 articles) Nano Letters
    [Show full text]
  • Cancer-Milestones December 2020
    www.nature.com/collections/cancer-milestones December 2020 Cancer Produced by: With support from: Nature Genetics and Nature Medicine Cancer MILESTONES S2 Foreword S3 Timeline S4 Routes to resistance S5 Tracking cancer in liquid biopsies S6 When cancer prevention went viral S7 A licence to kill S8 Sitting on the fence S9 Not a simple switch S10 Sequencing the secrets of the cancer genome S11 Unleashing the immune system against cancer S12 Engineering armed T cells for the fight S13 Oncohistones: epigenetic drivers of cancer S14 Tumour evolution: from linear paths to branched trees S15 Undruggable? Inconceivable S16 Good bacteria make for good cancer therapy S17 The AI revolution in cancer Credit: S.Fenwick/Springer Nature Limited CITING THE MILESTONES VISIT THE SUPPLEMENT ONLINE SUBSCRIPTIONS AND CUSTOMER SERVICES Nature Milestones in Cancer includes Milestone articles written The Nature Milestones in Cancer supplement can be found at Springer Nature, Subscriptions, by our editors and an online Collection of previously published www.nature.com/collections/cancer-milestones Cromwell Place, Hampshire International Business Park, material. To cite the full project, please use Nature Milestones: Lime Tree Way, Basingstoke, Cancer https://www.nature.com/collections/cancer-milestones CONTRIBUTING JOURNALS Hampshire RG24 8YJ, UK (2020). Should you wish to cite any of the individual Milestones, BMC Cancer, Nature, Nature Cancer, Nature Communications, Tel: +44 (0) 1256 329242 please list Author, A. Title. Nature Milestones: Cancer <Article URL> Nature Genetics, Nature Medicine, Nature Reviews Cancer, [email protected] (2020). For example, Milestone 1 is Valtierra, I. Routes to resistance. Nature Reviews Clinical Oncology, Nature Reviews Drug Discovery, Customer serviCes: www.nature.com/help Nature Milestones: Cancer https://www.nature.com/articles/ Nature Reviews Gastroenterology & Hepatology, d42859-020-00069-6 (2020).
    [Show full text]
  • Understanding Biological Design from Synthetic Circuits
    REVIEWS MODELLING Synthetic biology: understanding biological design from synthetic circuits Shankar Mukherji* and Alexander van Oudenaarden‡ Abstract | An important aim of synthetic biology is to uncover the design principles of natural biological systems through the rational design of gene and protein circuits. Here, we highlight how the process of engineering biological systems — from synthetic promoters to the control of cell–cell interactions — has contributed to our understanding of how endogenous systems are put together and function. Synthetic biological devices allow us to grasp intuitively the ranges of behaviour generated by simple biological circuits, such as linear cascades and interlocking feedback loops, as well as to exert control over natural processes, such as gene expression and population dynamics. 10–12 Modularity One of the most astounding findings of the Human potential clinical applications . In this Review, however, A property of a system such Genome Project was that our genome contains as many we focus on how synthetic circuits help us to under- that it can be broken down into genes as that of Drosophila melanogaster. This finding stand how natural biological systems are genetically discrete subparts that perform begged the question: how do you get one organism to assembled and how they operate in organisms from specific tasks independently of look like a fly and another like a human with the same microbes to mammalian cells. In this light, synthetic the other subparts. number of genes? One possibility is that the rich rep- circuits have been crucial as simplified test beds in Bioremediation ertoire of non-protein-coding sequences found in the which to refine our ideas of how similarly structured The treatment of pollution with genomes of complex organisms adds many new parts natural networks function, and they have served as microorganisms.
    [Show full text]
  • Using Open Access Literature to Guide Full-Text Query Formulation Heather A
    Using open access literature to guide full-text query formulation Heather A. Piwowar and Wendy W. Chapman Background Much scientific knowledge is contained in the details of the full-text biomedical literature. Most research in automated retrieval presupposes that the target literature can be downloaded and preprocessed prior to query. Unfortunately, this is not a practical or maintainable option for most users due to licensing restrictions, website terms of use, and sheer volume. Scientific article full-text is increasingly queriable through portals such as PubMed Central, Highwire Press, Scirus, and Google Scholar. However, because these portals only support very basic Boolean queries and full text is so expressive, formulating an effective query is a difficult task for users. We propose improving the formulation of full-text queries by using the open access literature as a proxy for the literature to be searched. We evaluated the feasibility of this approach by building a high-precision query for identifying studies that perform gene expression microarray experiments. Methodology and Results We built decision rules from unigram and bigram features of the open access literature. Minor syntax modifications were needed to translate the decision rules into the query languages of PubMed Central, Highwire Press, and Google Scholar. We mapped all retrieval results to PubMed identifiers and considered our query results as the union of retrieved articles across all portals. Compared to our reference standard, the derived full- text query found 56% (95% confidence interval, 52% to 61%) of intended studies, and 90% (86% to 93%) of studies identified by the full-text search met the reference standard criteria.
    [Show full text]
  • List Stranica 1 Od
    list product_i ISSN Primary Scheduled Vol Single Issues Title Format ISSN print Imprint Vols Qty Open Access Option Comment d electronic Language Nos per volume Available in electronic format 3 Biotech E OA C 13205 2190-5738 Springer English 1 7 3 Fully Open Access only. Open Access. Available in electronic format 3D Printing in Medicine E OA C 41205 2365-6271 Springer English 1 3 1 Fully Open Access only. Open Access. 3D Display Research Center, Available in electronic format 3D Research E C 13319 2092-6731 English 1 8 4 Hybrid (Open Choice) co-published only. with Springer New Start, content expected in 3D-Printed Materials and Systems E OA C 40861 2363-8389 Springer English 1 2 1 Fully Open Access 2016. Available in electronic format only. Open Access. 4OR PE OF 10288 1619-4500 1614-2411 Springer English 1 15 4 Hybrid (Open Choice) Available in electronic format The AAPS Journal E OF S 12248 1550-7416 Springer English 1 19 6 Hybrid (Open Choice) only. Available in electronic format AAPS Open E OA S C 41120 2364-9534 Springer English 1 3 1 Fully Open Access only. Open Access. Available in electronic format AAPS PharmSciTech E OF S 12249 1530-9932 Springer English 1 18 8 Hybrid (Open Choice) only. Abdominal Radiology PE OF S 261 2366-004X 2366-0058 Springer English 1 42 12 Hybrid (Open Choice) Abhandlungen aus dem Mathematischen Seminar der PE OF S 12188 0025-5858 1865-8784 Springer English 1 87 2 Universität Hamburg Academic Psychiatry PE OF S 40596 1042-9670 1545-7230 Springer English 1 41 6 Hybrid (Open Choice) Academic Questions PE OF 12129 0895-4852 1936-4709 Springer English 1 30 4 Hybrid (Open Choice) Accreditation and Quality PE OF S 769 0949-1775 1432-0517 Springer English 1 22 6 Hybrid (Open Choice) Assurance MAIK Acoustical Physics PE 11441 1063-7710 1562-6865 English 1 63 6 Russian Library of Science.
    [Show full text]
  • Curriculum Vitae – WENJUN ZHANG
    Curriculum Vitae – WENJUN ZHANG Department of Chemical and Biomolecular Engineering, University of California, Berkeley 201 Gilman Hall, Berkeley, CA 94720 http://www.cchem.berkeley.edu/wzgrp Tel: (510)643-8682, [email protected] https://scholar.google.com/citations?hl=en&user=NUYglIoAAAAJ&view_op=list_works&sortby=pubdate PROFESSIONAL EXPERIENCE Co-director, Agilent/UC Berkeley Synthetic Biology Institute (SBI) 2019 to current Associate Professor, Dept. of Chemical and Biomolecular Engineering, UC Berkeley 2018 to current Biologist Faculty Sci/Engr, Lawrence Berkeley National Laboratory 2014 to current Assistant Professor, Dept. of Chemical and Biomolecular Engineering, UC Berkeley 2011-2018 EDUCATION Research Fellow, Harvard Medical School (adviser: Christopher T. Walsh) 2009-2011 Ph.D., Chemical Engineering, University of California, Los Angeles (adviser: Yi Tang) 2004-2009 M.S., Biochemistry and Molecular Biology, Nanjing University, China (adviser: Genxi Li) 2002-2004 B.S., Biochemistry, DII, Nanjing University, China 1998-2002 AWARDS AND HONORS Presidential Early Career Award for Scientists and Engineers (PECASE) (2019) Scialog Fellow, Research Corporation and the Gordon and Betty Moore Foundation (2018) American Cancer Society Research Scholar (2017) Chau Hoi Shuen Foundation Women in Science Program New Research Grant Award (2017) Chan Zuckerberg Biohub Investigator (2017) Alfred P . Sloan Research Fellow (2016) Paul Saltman Memorial Award in Bioinorganic Chemistry (2016) NIH Director's New Innovator Award (2015) Hellman Fellow (2015) F1000Prime Faculty (Chemical Biology, Small Molecule Chemistry section) (2015) The Charles R. Wilke Endowed Chair in Chemical Engineering, UC Berkeley (2014) University of California Cancer Research Coordinating Committee Research Award (2013) Pew Scholar (2012) Energy Biosciences Institute Proposal Award (2011, 2014) Outstanding Ph.D.
    [Show full text]
  • Michael Lynch
    1 Michael Lynch Center for Mechanisms of Evolution, Biodesign Institute Arizona State University Tempe, AZ 85287 Phone: 480-965-0868 Email: [email protected] Birth: 6 December 1951, Auburn, New York Undergraduate education: St. Bonaventure University, Biology - B.S., 1973. Graduate education: University of Minnesota, Ecology and Behavioral Biology - Ph.D., 1977 (advisor: J. Shapiro). Areas of Interest and Research: The integration of molecular and cellular biology, genetics, and evolution; population and quantitative genetics; molecular, genomic, and phenotypic evolution. Select Professional Activities and Service: Director, Biodesign Center for Mechanisms of Evolution, Arizona State University, 2017 – present. Professor, School of Life Sciences, Arizona State University, 2017 – present. Class of 1954 Professor, 2011 – 2017. Distinguished Professor, Indiana University, 2005 – 2017. Professor; Biology, Indiana University, 2001 – 2004. Adjunct Professor, Computer Science, Indiana University, 2014 – 2017. Adjunct Professor, Physics, Indiana University, 2015 – 2017. Professor; Biology, University of Oregon, 1989 – 2001. Director, Ecology and Evolution Program, Univ. of Oregon, 1989 – 1993, 1996 – 2000. Asst., Assoc., Full Professor; Ecology, Ethology, and Evolution; University of Illinois, 1977 – 1989. Co-director, NSF IGERT Training Grant in Evolution, Development, and Genomics, 1999 – 2004. Director, NSF Genetic Mechanisms of Evolution Training Grant, 1990 – 2000. President, Genetics Society of America, 2013. President, Society for Molecular Biology and Evolution, 2009. President, American Genetic Association, 2007. President, Society for the Study of Evolution, 2000. Chair-elect, Section on Biological Sciences American Association for the Advancement of Science, 2017-2020. Vice-president, Genetics Society of America, 2012. Vice-president, Society for the Study of Evolution, 1994. Council Member, Society for the Study of Evolution, 1991 – 1993.
    [Show full text]
  • THE OA EFFECT: HOW DOES OPEN ACCESS AFFECT the USAGE of SCHOLARLY BOOKS? White Paper
    springernature.com Illustration inspired by the work of Jean-Claude Bradley Open Research THE OA EFFECT: HOW DOES OPEN ACCESS AFFECT THE USAGE OF SCHOLARLY BOOKS? White paper Open Research: Journals, books, data and tools from: 2 The OA effect: How does open access affect the usage of scholarly books? springernature.com Contents Authors Foreword . 3 Christina Emery, Mithu Lucraft, Executive summary . 4 Agata Morka, Ros Pyne Introduction . 5 November 2017 Part 1: Quantitative findings . 6 Summary . 6 Downloads . 7 Citations and mentions . 11 Part 2: Qualitative findings . 13 Summary . 13 Reasons for publishing open access . 14 Experience of publishing open access . 15 The future of open access . 16 Discussion . 18 Conclusion and recommendations . 20 Acknowledgements . 22 Contacts . 23 About Springer Nature and OA books . 24 Appendices . 26 Appendix 1: Definitions and limitations . 26 Appendix 2: Methodology . 27 Appendix 3: Top 10 downloaded books . 29 Appendix 4: Interviewed authors and funders . 30 Appendix 5: Author questionnaire . 32 Appendix 6: Funder questionnaire . 33 Appendix 7: References . 34 This work is licensed under a Creative Commons Attribution International License (CC BY 4.0) The OA effect: How does open access affect the usage of scholarly books? springernature.com 3 Foreword Springer Nature was created in 2015, but from our earliest days as Springer, Palgrave Macmillan and Nature, we have been publishing monographs and long-form research for some 175 years. The changing environment for book publishing has created both opportunities and challenges for researchers and their funders, for publishers, and for the wider community of readers and educators. As a publisher, we have championed new models of scholarship, introducing ebooks in 2006, and our first open access (OA) book in 2011.
    [Show full text]
  • Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19
    Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Available online at www.sciencedirect.com ScienceDirect Editorial overview: Membrane traffic in the time of COVID-19 Frances M. Brodsky and Jennifer L. Stow Current Opinion in Cell Biology 2020, 65:iii–v This overview comes from a themed issue on Membrane Trafficking Edited by Frances M. Brodsky and Jennifer L. Stow https://doi.org/10.1016/j.ceb.2020.09.003 0955-0674/© 2020 Published by Elsevier Ltd. Frances M. Brodsky We write this editorial emerging from lockdown in countries across the Division of Biosciences, University College world in the face of the COVID-19 pandemic. These have been chal- London, Gower Street, London, WC1E 6BT, lenging, frightening, and too often catastrophic times for many. Such times UK lead to evaluation of one’s own enterprise in the context of a global *Corresponding author: Brodsky, Frances M.
    [Show full text]
  • SUBMISSION from SPRINGER NATURE Making Plan S Successful
    PLAN S IMPLEMENTATION GUIDANCE: SUBMISSION FROM SPRINGER NATURE Springer Nature welcomes the opportunity to provide feedback to the cOAlition S Implementation Guidance and contribute to the discussion on how the transition to Open Access (OA) can be accelerated. Our submission below focuses mainly on the second question posed in the consultation: Are there other mechanisms or requirements funders should consider to foster full and immediate Open Access of research outputs? Making Plan S successful: a commitment to open access Springer Nature is dedicated to accelerating the adoption of Open Access (OA) publishing and Open Research techniques. As the world’s largest OA publisher we are a committed partner for cOAlition S funders in achieving this goal which is also the primary focus of Plan S. Our recommendations below are therefore presented with the aim of achieving this goal. As a first mover, we know the (multiple) challenges that need to be overcome: funding flows that need to change, a lack of cooperation in funder policies, a lack of global coordination, the need for a cultural change in researcher assessment and metrics in research, academic disciplines that lack OA resources, geographic differences in levels of research output making global “Publish and Read” deals difficult and, critically, an author community that does not yet view publishing OA as a priority. While this uncertainty remains, we need the benefits of OA to be better described and promoted as well as support for the ways that enable us and other publishers to cope with the rapidly increasing demand. We therefore propose cOAlition S adopt the following six recommendations which we believe are necessary to deliver Plan S’s primary goal of accelerating the take-up of OA globally while minimising costs to funders and other stakeholders: 1.
    [Show full text]